The Effect of Cataract on Photoentrainment of the Circadian Rhythm in Humans (CIRCAT)

February 9, 2015 updated by: Adam Elias Brøndsted, Glostrup University Hospital, Copenhagen

Cataract is globally the most common cause of blindness and in Denmark the operation with - 50.000 treatments per year - is the most common eye operation. The cause of cataract is growth and denaturation of the lens proteins. This leads to an increased absorption of blue light and increased light scatter. This may affect newly discovered cells in the retina that are involved in the regulation of the circadian rhythm. When the internal circadian rhythm is not synchronized with the external day and night a phase-shift occurs. Most people know of this discomfort as jet-lag, but the consequences may be much more severe such as heighten risk of cancer and cardiovascular disease.

The goal of this project is to study how the circadian regulating cells of the retina is affected by cataract and by the operation. Cataract patients are studied before and after the operation with questionnaires, hormone and activity measurements and with a specialized pupil measurement that measures the indirect response of the circadian regulating cells to blue light.

Results from this study aim to shed light on the regulatory mechanisms of the eye on the circadian rhythm and how these are affected by cataract. Furthermore, choice of intraocular lens is evaluated. This may have impact on clinical practise especially with regard to choice of intraocular lens and widened indications for cataract surgery.

Study Overview

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Glostrup, Denmark, DK-2600
        • Glostrup University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age related/senile bilateral cataract
  • Eligible for phaco-emulsification on both eyes

Exclusion Criteria:

  • Known eye disease other than cataract.
  • Known systemic disease, which may affect the retina (untreated hypertension, DM etc.)
  • Known systemic disease, which may affect the lens.
  • Known psychiatric disease.
  • Known sleep or circadian rhythm disorder, not caused by lowered blue light transmission by the lens.
  • Per- and post operative complications
  • Use of drugs that may affect the sleep.

For a subpopulation also:

  • Poor cooperation.
  • Severe refraction abnormalities.
  • Previous eye surgery
  • Nystagmus
  • Congenital or acquired abnormalities of: eye lids and eye area, cornea or iris.
  • Use of medicine that may affect the pupillary response.
  • Use of drugs that may affect the pupillary response.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional Intra Ocular Lens (IOL)
Standard minimal incision cataract surgery by phacoemulsification and posterior intraocular lens implantation.
Standard operation with conventional IOL implantation
Experimental: Yellow Intra Ocular Lens (IOL)
Standard minimal incision cataract surgery by phacoemulsification and posterior intraocular lens implantation.
Standard operation with blue light filter Yellow IOL implantation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pupillary response to blue light
Time Frame: 1 year/1month
Measurement of the consensual light response to red (630 nm) and blue (470 nm)
1 year/1month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire
Time Frame: 1year/1month
Pittsburgh Sleep Quality Index and the Morningness Eveningness Questionnaire
1year/1month
Questionnaire
Time Frame: 1 year/1 month
Morningness-eveningness questionnaire
1 year/1 month
Melatonin day variety analysis
Time Frame: 1year/1month
Salivary samples collected with 4 hour interval during 24 hours. Analyzed for melatonin concentration with Radio Immuno Assay (RIA).
1year/1month
Actigraphy
Time Frame: 1year/1month
Activity measured during 7 days and 7 nights with the Spectrum Actiwatch, Respironics, Philips
1year/1month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adam E Brøndsted, MD, Glostrup UH

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

November 30, 2011

First Submitted That Met QC Criteria

September 17, 2012

First Posted (Estimate)

September 18, 2012

Study Record Updates

Last Update Posted (Estimate)

February 10, 2015

Last Update Submitted That Met QC Criteria

February 9, 2015

Last Verified

February 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CIRCAT

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on Conventional Intra Ocular Lens (IOL)

Subscribe